Intra-abdominal infections: considerations for the use of the carbapenems.
about
Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infectionsAntimicrobial resistance and the management of anaerobic infections.A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).
P2860
Intra-abdominal infections: considerations for the use of the carbapenems.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Intra-abdominal infections: considerations for the use of the carbapenems.
@ast
Intra-abdominal infections: considerations for the use of the carbapenems.
@en
type
label
Intra-abdominal infections: considerations for the use of the carbapenems.
@ast
Intra-abdominal infections: considerations for the use of the carbapenems.
@en
prefLabel
Intra-abdominal infections: considerations for the use of the carbapenems.
@ast
Intra-abdominal infections: considerations for the use of the carbapenems.
@en
P2093
P2860
P356
P1476
Intra-abdominal infections: considerations for the use of the carbapenems.
@en
P2093
David P Nicolau
Ioannis P Kioumis
Joseph L Kuti
P2860
P304
P356
10.1517/14656566.8.2.167
P407
P577
2007-02-01T00:00:00Z